Taxane induced neuropathy in patients affected by breast cancer: Literature review

Iuliis, Francesca De; Taglieri, Ludovica; Salerno, Gerardo; Lanza, Rosina; Scarpa, Susanna

doi:10.1016/j.critrevonc.2015.04.011

Cited by 82 publications

(62 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Due to the distressing and painful symptoms of CIPN, it might substantially affect the patients' quality of life and reduce their function ability temporarily or permanent. In addition, CIPN can lead to reductions in CTx dose or treatment interruptions, which eventually affects the overall survival of the patients [58,59].…”

Section: Cipnmentioning

confidence: 99%

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

et al. 2016

View full text Add to dashboard Cite

Breast cancer is the most common cancer in women worldwide, with an incidence of 1.7 million in 2012. Breast cancer and its treatments can bring along serious side effects such as fatigue, skin toxicity, lymphedema, pain, nausea, etc. These can substantially affect the patients' quality of life. Therefore, supportive care for breast cancer patients is an essential mainstay in the treatment. Low-level light therapy (LLLT) also named photobiomodulation therapy (PBMT) has proven its efficiency in general medicine for already more than 40 years. It is a noninvasive treatment option used to stimulate wound healing and reduce inflammation, edema, and pain. LLLT is used in different medical settings ranging from dermatology, physiotherapy, and neurology to dentistry. Since the last twenty years, LLLT is becoming a new treatment modality in supportive care for breast cancer. For this review, all existing literature concerning the use of LLLT for breast cancer was used to provide evidence in the following domains: oral mucositis (OM), radiodermatitis (RD), lymphedema, chemotherapy-induced peripheral neuropathy (CIPN), and osteonecrosis of the jaw (ONJ). The findings of this review suggest that LLLT is a promising option for the management of breast cancer treatment-related side effects. However, it still remains important to define appropriate treatment and irradiation parameters for each condition in order to ensure the effectiveness of LLLT.

show abstract

Section: Cipnmentioning

confidence: 99%

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Treatments associated with a higher incidence of CIPN include those with platinum drugs, vinca alkaloids, or taxanes [9]. The estimated occurrence of CIPN among patients undergoing chemotherapy varied widely across previous investigations, largely reflecting differences in study designs, populations studied, specificities of the treatment schemes, and lack of uniformity in CIPN assessment methods [10][11][12][13][14].…”

Section: Introductionmentioning

confidence: 99%

Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study

Pereira

Fontes

Sonin

et al. 2015

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…Paclitaxel induces a chronic, dose-dependent sensory peripheral neuropathy that is characterized by tingling, numbness, increased sensitivity to cold and touch, and burning pain of the distal extremities, and this side effect occurs with an incidence of up to 70%-80% in patients with MBC (1). With cumulative dosing, the painful symptoms increase in severity and can persist for years (2), or even cause a lifelong functional impairment that impacts quality of life (3).…”

Section: Introductionmentioning

confidence: 99%

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

Leblanc¹,

Sprowl²,

Alberti³

et al. 2018

Journal of Clinical Investigation

View full text Add to dashboard Cite

Taxane induced neuropathy in patients affected by breast cancer: Literature review

Cited by 82 publications

References 87 publications

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

Contact Info

Product

Resources

About